Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-18T02:11:07.615Z Has data issue: false hasContentIssue false

Substance Use Disorders and Psychiatric Comorbidity

Published online by Cambridge University Press:  31 July 2026

K. Taleb*
Affiliation:
Psychiatry
F. Laajili
Affiliation:
Arrazi Hospital, Salé, Morocco
H. Ballouk
Affiliation:
Psychiatry
Z. Bencharfa
Affiliation:
Psychiatry
F. El Omari
Affiliation:
Psychiatry
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Introduction

Substance use disorders (SUDs) are often associated with other mental disorders—psychotic, mood, or anxiety—complicating treatment and worsening clinical and social outcomes.

Objectives

To describe the main psychiatric comorbidities among patients with SUDs and examine their relationship with substance type.

Methods

A retrospective descriptive study based on clinical records of patients consulting for SUDs. Collected data included sociodemographic profile, substances used, psychiatric diagnoses, and treatments.

Results

Results (N = 102):

  • - Gender: predominantly male (~90%).

  • - Age: mostly 20–40 years.

  • - Main substances: tobacco (85%), cannabis (70%), alcohol (56%).

  • - Comorbid disorders: psychotic (45%), mood (30%), anxiety (15%), personality (10%).

  • - Polysubstance use: >50% of patients.

  • - Treatments: antipsychotics (79%), antidepressants (55%), anxiolytics (38%).

Conclusions

SUDs are commonly associated with severe psychiatric comorbidities. Systematic screening and a dual-diagnosis approach are key to enhancing prognosis and patient reintegration.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.